Aesthetic Medical International Holdings Group Limited (AIH)
NASDAQ: AIH · IEX Real-Time Price · USD
0.450
+0.043 (10.57%)
At close: Apr 24, 2024, 3:59 PM
0.471
+0.021 (4.67%)
After-hours: Apr 24, 2024, 4:29 PM EDT

Company Description

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China and Singapore.

The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and ultraviolet light treatments.

It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services.

The company was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.

Aesthetic Medical International Holdings Group Limited
Aesthetic Medical International Holdings Group logo
Country China
Founded 1997
IPO Date Oct 25, 2019
Industry Medical Care Facilities
Sector Healthcare
Employees 1,167
CEO Dr. Pengwu Zhou

Contact Details

Address:
4068 Qiaoxiang Road, Nanshan District
Shenzhen, F4 518053
China
Phone 917 609-0333
Website ir.aihgroup.net

Stock Details

Ticker Symbol AIH
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $12.00
CIK Code 0001757143
CUSIP Number 00809M104
ISIN Number US00809M1045
SIC Code 8093

Key Executives

Name Position
Dr. Pengwu Zhou Co-Founder and Non-Executive Co-Chairman of the Board
Chen Zhang Executive co-chairman of the Board
Ding Wenting Co-Founder and Chief Marketing Officer
Guanhua Wu Chief Financial Officer
Qing Hu Chief Operating Officer
Derrick Shi Investor Relations Associate Director
Dr. Yitao Zhou Chief Medical Technique Officer

Latest SEC Filings

Date Type Title
Mar 8, 2024 6-K Report of foreign issuer
Dec 13, 2023 6-K Report of foreign issuer
Sep 22, 2023 20-F/A Filing
Sep 8, 2023 6-K Report of foreign issuer
Sep 5, 2023 6-K Report of foreign issuer
Aug 17, 2023 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Aug 17, 2023 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Aug 17, 2023 6-K Report of foreign issuer
May 23, 2023 RW Filing
May 17, 2023 6-K Report of foreign issuer